。$四季教育(FEDU)$ $华富教育(WAFU)$查看全文
智通财经APP讯,先声药业(02096)发布公告,该公司与Kazia Therapeutics Limited(Kazia)合作的创新药SIM0395(Paxalisib)于2021年12月6日获得中国国家药品监督管理局签发的药物临床试验批准通知书,拟用于胶质母细胞瘤(GBM),包括新诊断和... 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-236509 Act: 34 Size: 25 MB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-213178 Act: 34 Size: 45 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-207835 Act: 34 Size: 40 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-188189 Act: 34 Size: 32 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-185479 Act: 34 Size: 62 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-179289 Act: 34 Size: 7 MB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-176610 Act: 34 Size: 35 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-115103 Act: 34 Size: 294 KB 网页链接
$Kazia Therapeutics(KZIA)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-22-115084 Act: 33 Size: 486 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-22-095557 Act: 34 Size: 34 KB 网页链接